Dimethoxy(methyl)(3,3,3-trifluoropropyl)silane

We are Dimethoxy(methyl)(3,3,3-trifluoropropyl)silane CAS:358-67-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


Chemical Name:Dimethoxy(methyl)(3,3,3-trifluoropropyl)silane
CAS.NO:358-67-8
Synonyms:(3,3,3-Tri FluoroPropyl) Methyl Di-Methoxy Silane;
(3,3,3-TRIFLUOROPROPYL)METHYLDIMETHOXYSILANE; 3,3,3-Trifluorpropylmethyldimethoxysilan; dimethoxy-methyl-(3,3,3-trifluoropropyl)silane;
Molecular Formula:C6H13F3O2Si
Molecular Weight:202.24700
 
Physical and Chemical Properties:
Density:1.089;
Melting point:oC;
Boiling point:85oC;
Flash point:58oC;
Index of Refraction:1.358;
 
Specification:
Appearance:Colorless clear liquid
Purity(GC):≥98.0%
 
Packing:210 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It can be used for production of Fluorosilicone fluid.can be used for production of Fluorosilicone resin.
 

Dimethoxy(methyl)(3,3,3-trifluoropropyl)silane


Related News: At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances.N- (trifenilmetil) -5- (4-bromometilbifenil-2-il-) tetrazol CAS:124750-51-2 It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.(2S)-Amino(3-hydroxyadamantan-1-yl)acetic acid The unit of the British drugmaker, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new drug application.1,3,5-trichloro-2-(2-chloroethoxy)benzene CAS:13001-29-1 Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells.The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured.

Related Products
Product Name
Abarelix View Details
N-(3-Aminopropyl)-N-dodecyl-1,3-propanediamine Cas:2372-82-9 View Details
Osimertinib Cas:1421373-65-0 View Details
Trimethyl phosphite manufacturer naphthaline-2,6-dicarbonic acid Cas:2351-36-2 manufacturer N-[5-(diphenylphosphorylmethyl)-4-(4-fluorophenyl)-6-propan-2-ylpyrimidin-2-yl]-N-methylmethanesulfonamide manufacturer CAS:2652-38-2 octylcyclohexyl alcohol manufacturer 3,4,5-trimethoxycinmic acid Cas:90-50-6 manufacturer